SUBSCRIBE
SUBSCRIBE

Editas Medicine

AWARDS
  • NextGen Class of 2015
NEWS
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Genetown
Editas Medicine Stock Surge Driven by Supportive Friends and Their Bank Accounts
March 9, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Editas Medicine, Juno Therapeutics Hammer Out $727 Million CAR T R&D Deal
May 27, 2015
 · 
10 min read
Load More
JOBS
IN THE PRESS
Press Releases
Editas Medicine Announces Third Quarter 2025 Results and Business Updates
November 10, 2025
 · 
9 min read
Press Releases
Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025
November 4, 2025
 · 
1 min read
Press Releases
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
October 10, 2025
 · 
2 min read
Press Releases
Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences
October 7, 2025
 · 
2 min read
Press Releases
Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate
September 3, 2025
 · 
7 min read
Press Releases
Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate
August 29, 2025
 · 
1 min read
Press Releases
Editas Medicine to Participate in Upcoming September 2025 Investor Conferences
August 28, 2025
 · 
1 min read
Press Releases
Editas Medicine Announces Second Quarter 2025 Results and Business Updates
August 13, 2025
 · 
9 min read
Press Releases
Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June
June 12, 2025
 · 
3 min read
Press Releases
Editas Medicine Reports New In Vivo Data Highlighting the Potential of Editas’ Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting
May 15, 2025
 · 
4 min read
Load More